Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...
Cellares has raised a $257 million Series D financing, bringing its total funding to $612 million. The latest comes as the cell therapy manufacturing company accelerates plans to industrialize ...
Mark Zuckerberg backs $500 million push to build AI models of human cells as part of long-term effort to cure disease.
Moleculent Launches Early Access Program to Help Researchers Decode Cell-Cell Communication at Scale
New functional biology platform enables high-plex analysis of cell-cell interactions directly in patient-derived FFPE samples Techstart Early Access Program offers selected partners the opportunity to ...
SAN DIEGO--(BUSINESS WIRE)--Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA ...
A team of Chinese researchers has developed two new genome editing technologies, known collectively as Programmable Chromosome Engineering (PCE) systems. The study, published online in Cell on August ...
Chinese hamster ovary (CHO) cell lines are one of the most-used cell-based protein expression systems for therapeutics, thanks to their ability to support post-translational modifications such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results